(Circulation. 2000;101:2047.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Cooper Institute (M.W., J.B.K., S.N.B.) and the Cooper Clinic (L.W.G., T.L.M.), Dallas, and the Department of Medicine (M.P.S.), University of Texas Health Science Center, San Antonio, Tex.
BackgroundAlthough medical textbooks usually classify fasting plasma glucose <70 or 80 mg/dL (<3.89 or 4.44 mmol/L) as abnormal, the prognosis for patients with low fasting plasma glucose is unclear.
Methods and ResultsWe conducted prospective cohort studies among 40 069 men and women to investigate the association between fasting plasma glucose levels and cardiovascular disease and all-cause mortality. We documented a U-shaped relation between fasting plasma glucose and mortality. In addition to diabetes and impaired fasting glucose levels, low fasting plasma glucose levels were also associated with high mortality. After multivariate adjustment for age, sex, study population, ethnicity, current smoking status, high blood pressure, total cholesterol, body mass index, triglycerides, history of cardiovascular disease and cancer, and a family history of cardiovascular disease, patients with fasting plasma glucose <70 mg/dL (<3.89 mmol/L) had a 3.3-fold increased risk of cardiovascular disease mortality, and patients with fasting plasma glucose 70 to 79 mg/dL (3.89 to 4.43 mmol/L) had a 2.4-fold increased risk compared with the risk in patients with fasting plasma glucose 80 to 109 mg/dL (4.44 to 6.05 mmol/L) (tests for trend P<0.0001). Participants with low fasting plasma glucose levels also had increased risk of all-cause mortality (test for trend P<0.0001).
ConclusionsParticipants with low fasting plasma glucose levels had a high risk of cardiovascular disease and all-cause mortality.
Key Words: glucose cardiovascular diseases mortality
This article has been cited by other articles:
![]() |
S. E. Vermeer, W. Sandee, A. Algra, P. J. Koudstaal, L. J. Kappelle, D. W.J. Dippel, and on behalf of the Dutch TIA Trial Study Group Impaired Glucose Tolerance Increases Stroke Risk in Nondiabetic Patients With Transient Ischemic Attack or Minor Ischemic Stroke Stroke, June 1, 2006; 37(6): 1413 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Sorkin, D. C. Muller, J. L. Fleg, and R. Andres The Relation of Fasting and 2-h Postchallenge Plasma Glucose Concentrations to Mortality: Data from the Baltimore Longitudinal Study of Aging with a critical review of the literature Diabetes Care, November 1, 2005; 28(11): 2626 - 2632. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Wen, T. Y. D. Cheng, S. P. Tsai, H. L. Hsu, and S. L. Wang Increased Mortality Risks of Pre-Diabetes (Impaired Fasting Glucose) in Taiwan Diabetes Care, November 1, 2005; 28(11): 2756 - 2761. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tanne, N. Koren-Morag, and U. Goldbourt Fasting Plasma Glucose and Risk of Incident Ischemic Stroke or Transient Ischemic Attacks: A Prospective Cohort Study Stroke, October 1, 2004; 35(10): 2351 - 2355. [Abstract] [Full Text] [PDF] |
||||
![]() |
The DECODE Study Group Is the Current Definition for Diabetes Relevant to Mortality Risk From All Causes and Cardiovascular and Noncardiovascular Diseases? Diabetes Care, March 1, 2003; 26(3): 688 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tamakoshi, H. Yatsuya, T. Kondo, Y. Hori, H. Zhang, M. Ishikawa, C. Murata, R. Otsuka, S. Zhu, and H. Toyoshima U-Shaped Association Between White Blood Cell Count and Fasting Plasma Glucose Level Diabetes Care, March 1, 2003; 26(3): 950 - 950. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |